STERIS plc (STE)
USD 224.01
(1.32%)
USD 224.01
(1.32%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 4.74 Billion USD | 0.29% |
| 2023 | 4.73 Billion USD | -3.53% |
| 2022 | 4.9 Billion USD | 82.93% |
| 2021 | 2.68 Billion USD | 32.9% |
| 2020 | 2.01 Billion USD | 6.97% |
| 2019 | 1.88 Billion USD | -4.83% |
| 2018 | 1.98 Billion USD | -6.21% |
| 2017 | 2.11 Billion USD | -8.37% |
| 2016 | 2.3 Billion USD | 124.94% |
| 2015 | 1.02 Billion USD | 21.27% |
| 2014 | 845.91 Million USD | 3.9% |
| 2013 | 814.12 Million USD | 39.64% |
| 2012 | 583.03 Million USD | -8.62% |
| 2011 | 638.02 Million USD | 31.85% |
| 2010 | 483.9 Million USD | -3.06% |
| 2009 | 499.2 Million USD | -6.31% |
| 2008 | 532.81 Million USD | 22.52% |
| 2007 | 434.87 Million USD | -5.08% |
| 2006 | 458.14 Million USD | 6.52% |
| 2005 | 430.08 Million USD | 10.53% |
| 2004 | 389.11 Million USD | 19.56% |
| 2003 | 325.46 Million USD | -8.17% |
| 2002 | 354.42 Million USD | -15.73% |
| 2001 | 420.59 Million USD | -12.83% |
| 2000 | 482.48 Million USD | 12.18% |
| 1999 | 430.1 Million USD | 15.19% |
| 1998 | 373.37 Million USD | 52.52% |
| 1997 | 244.8 Million USD | 964.35% |
| 1996 | 23 Million USD | 123.3% |
| 1995 | 10.3 Million USD | 37.33% |
| 1994 | 7.5 Million USD | 87.5% |
| 1993 | 4 Million USD | 48.15% |
| 1992 | 2.7 Million USD | -6.9% |
| 1991 | 2.9 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 5 Billion USD | -1.66% |
| 2024 Q1 | 4.6 Billion USD | -2.72% |
| 2024 Q2 | 5.09 Billion USD | 10.54% |
| 2024 Q4 | 4.74 Billion USD | -5.17% |
| 2024 FY | 4.74 Billion USD | 0.29% |
| 2023 Q3 | 4.75 Billion USD | 1.61% |
| 2023 FY | 4.73 Billion USD | -3.53% |
| 2023 Q4 | 4.73 Billion USD | -0.35% |
| 2023 Q2 | 4.67 Billion USD | -1.94% |
| 2023 Q1 | 4.76 Billion USD | -2.83% |
| 2022 Q4 | 4.9 Billion USD | -3.13% |
| 2022 Q2 | 5.2 Billion USD | -5.59% |
| 2022 Q1 | 5.51 Billion USD | 105.59% |
| 2022 FY | 4.9 Billion USD | 82.93% |
| 2022 Q3 | 5.06 Billion USD | -2.71% |
| 2021 FY | 2.68 Billion USD | 32.9% |
| 2021 Q3 | 2.7 Billion USD | 47.67% |
| 2021 Q4 | 2.68 Billion USD | -0.72% |
| 2021 Q1 | 1.87 Billion USD | -7.16% |
| 2021 Q2 | 1.83 Billion USD | -2.35% |
| 2020 Q3 | 1.93 Billion USD | -0.44% |
| 2020 Q2 | 1.94 Billion USD | -1.85% |
| 2020 Q1 | 1.98 Billion USD | 5.16% |
| 2020 Q4 | 2.01 Billion USD | 4.09% |
| 2020 FY | 2.01 Billion USD | 6.97% |
| 2019 Q1 | 1.95 Billion USD | -1.53% |
| 2019 Q4 | 1.88 Billion USD | -0.36% |
| 2019 FY | 1.88 Billion USD | -4.83% |
| 2019 Q2 | 1.89 Billion USD | -2.88% |
| 2019 Q3 | 1.89 Billion USD | -0.12% |
| 2018 Q1 | 2.11 Billion USD | 0.11% |
| 2018 Q3 | 2.03 Billion USD | -1.94% |
| 2018 Q4 | 1.98 Billion USD | -2.76% |
| 2018 FY | 1.98 Billion USD | -6.21% |
| 2018 Q2 | 2.07 Billion USD | -1.76% |
| 2017 Q1 | 2.24 Billion USD | -2.72% |
| 2017 Q3 | 2.11 Billion USD | -3.83% |
| 2017 Q4 | 2.11 Billion USD | -0.11% |
| 2017 FY | 2.11 Billion USD | -8.37% |
| 2017 Q2 | 2.2 Billion USD | -1.94% |
| 2016 Q2 | 1.21 Billion USD | 12.52% |
| 2016 Q1 | 1.08 Billion USD | 5.46% |
| 2016 Q3 | 2.36 Billion USD | 93.91% |
| 2016 Q4 | 2.3 Billion USD | -2.24% |
| 2016 FY | 2.3 Billion USD | 124.94% |
| 2015 Q2 | 959.54 Million USD | -2.73% |
| 2015 FY | 1.02 Billion USD | 21.27% |
| 2015 Q1 | 986.46 Million USD | 16.61% |
| 2015 Q4 | 1.02 Billion USD | 7.79% |
| 2015 Q3 | 951.71 Million USD | -0.82% |
| 2014 Q3 | 768.06 Million USD | -3.66% |
| 2014 Q2 | 797.22 Million USD | -0.71% |
| 2014 Q4 | 845.91 Million USD | 10.14% |
| 2014 Q1 | 802.89 Million USD | -1.38% |
| 2014 FY | 845.91 Million USD | 3.9% |
| 2013 Q2 | 751.1 Million USD | 31.78% |
| 2013 FY | 814.12 Million USD | 39.64% |
| 2013 Q3 | 844.87 Million USD | 12.48% |
| 2013 Q4 | 814.12 Million USD | -3.64% |
| 2013 Q1 | 569.95 Million USD | -2.24% |
| 2012 FY | 583.03 Million USD | -8.62% |
| 2012 Q4 | 583.03 Million USD | -2.18% |
| 2012 Q3 | 596 Million USD | 0.13% |
| 2012 Q2 | 595.25 Million USD | -0.98% |
| 2012 Q1 | 601.17 Million USD | -5.78% |
| 2011 Q3 | 600.99 Million USD | 6.57% |
| 2011 FY | 638.02 Million USD | 31.85% |
| 2011 Q1 | 569.71 Million USD | 17.73% |
| 2011 Q2 | 563.95 Million USD | -1.01% |
| 2011 Q4 | 638.02 Million USD | 6.16% |
| 2010 Q2 | 462.46 Million USD | 2.44% |
| 2010 FY | 483.9 Million USD | -3.06% |
| 2010 Q4 | 483.9 Million USD | -13.98% |
| 2010 Q3 | 562.52 Million USD | 21.64% |
| 2010 Q1 | 451.45 Million USD | -9.56% |
| 2009 Q3 | 480.05 Million USD | -9.33% |
| 2009 Q1 | 500.7 Million USD | -6.03% |
| 2009 FY | 499.2 Million USD | -6.31% |
| 2009 Q4 | 499.2 Million USD | 3.99% |
| 2009 Q2 | 529.47 Million USD | 5.75% |
| 2008 FY | 532.81 Million USD | 22.52% |
| 2008 Q1 | 415.22 Million USD | -4.52% |
| 2008 Q2 | 435.22 Million USD | 4.82% |
| 2008 Q3 | 440.85 Million USD | 1.29% |
| 2008 Q4 | 532.81 Million USD | 20.86% |
| 2007 Q1 | 492.35 Million USD | 7.47% |
| 2007 FY | 434.87 Million USD | -5.08% |
| 2007 Q4 | 434.87 Million USD | 3.57% |
| 2007 Q3 | 419.89 Million USD | -6.21% |
| 2007 Q2 | 447.7 Million USD | -9.07% |
| 2006 Q1 | 419.32 Million USD | -2.5% |
| 2006 Q4 | 458.14 Million USD | 17.85% |
| 2006 FY | 458.14 Million USD | 6.52% |
| 2006 Q3 | 388.74 Million USD | -6.41% |
| 2006 Q2 | 415.37 Million USD | -0.94% |
| 2005 Q3 | 387.7 Million USD | 4.89% |
| 2005 FY | 430.08 Million USD | 10.53% |
| 2005 Q1 | 383.59 Million USD | -1.42% |
| 2005 Q2 | 369.62 Million USD | -3.64% |
| 2005 Q4 | 430.08 Million USD | 10.93% |
| 2004 Q3 | 357.32 Million USD | 0.97% |
| 2004 FY | 389.11 Million USD | 19.56% |
| 2004 Q1 | 382.34 Million USD | 17.48% |
| 2004 Q2 | 353.89 Million USD | -7.44% |
| 2004 Q4 | 389.11 Million USD | 8.9% |
| 2003 Q2 | 329.28 Million USD | -4.34% |
| 2003 Q4 | 325.46 Million USD | 6.14% |
| 2003 Q1 | 344.23 Million USD | -2.87% |
| 2003 Q3 | 306.63 Million USD | -6.88% |
| 2003 FY | 325.46 Million USD | -8.17% |
| 2002 FY | 354.42 Million USD | -15.73% |
| 2002 Q4 | 354.42 Million USD | -1.21% |
| 2002 Q2 | 371.75 Million USD | -2.37% |
| 2002 Q3 | 358.77 Million USD | -3.49% |
| 2002 Q1 | 380.76 Million USD | -9.47% |
| 2001 Q3 | 423.69 Million USD | -6.25% |
| 2001 FY | 420.59 Million USD | -12.83% |
| 2001 Q4 | 420.59 Million USD | -0.73% |
| 2001 Q1 | 450.7 Million USD | -6.59% |
| 2001 Q2 | 451.95 Million USD | 0.28% |
| 2000 Q1 | 442.3 Million USD | 2.84% |
| 2000 Q4 | 482.48 Million USD | 2.96% |
| 2000 Q2 | 464.3 Million USD | 4.97% |
| 2000 FY | 482.48 Million USD | 12.18% |
| 2000 Q3 | 468.6 Million USD | 0.93% |
| 1999 Q2 | 429.8 Million USD | 16.96% |
| 1999 FY | 430.1 Million USD | 15.19% |
| 1999 Q1 | 367.47 Million USD | -1.58% |
| 1999 Q4 | 430.1 Million USD | -1.53% |
| 1999 Q3 | 436.8 Million USD | 1.63% |
| 1998 Q4 | 373.37 Million USD | -6.18% |
| 1998 Q1 | 232.98 Million USD | -4.82% |
| 1998 Q2 | 399.01 Million USD | 71.26% |
| 1998 Q3 | 397.98 Million USD | -0.26% |
| 1998 FY | 373.37 Million USD | 52.52% |
| 1997 Q1 | 320.2 Million USD | 1292.17% |
| 1997 Q2 | 219.5 Million USD | -31.45% |
| 1997 Q3 | 264.5 Million USD | 20.5% |
| 1997 FY | 244.8 Million USD | 964.35% |
| 1997 Q4 | 244.8 Million USD | -7.45% |
| 1996 FY | 23 Million USD | 123.3% |
| 1996 Q1 | 7.9 Million USD | -23.3% |
| 1996 Q2 | 9.6 Million USD | 21.52% |
| 1996 Q3 | 12.7 Million USD | 32.29% |
| 1996 Q4 | 23 Million USD | 81.1% |
| 1995 Q2 | 9 Million USD | 45.16% |
| 1995 Q3 | 7.9 Million USD | -12.22% |
| 1995 Q4 | 10.3 Million USD | 30.38% |
| 1995 Q1 | 6.2 Million USD | -17.33% |
| 1995 FY | 10.3 Million USD | 37.33% |
| 1994 Q4 | 7.5 Million USD | 20.97% |
| 1994 Q3 | 6.2 Million USD | 51.22% |
| 1994 FY | 7.5 Million USD | 87.5% |
| 1994 Q1 | 3.5 Million USD | -12.5% |
| 1994 Q2 | 4.1 Million USD | 17.14% |
| 1993 Q2 | 3.3 Million USD | -15.38% |
| 1993 FY | 4 Million USD | 48.15% |
| 1993 Q1 | 3.9 Million USD | 44.44% |
| 1993 Q4 | 4 Million USD | 37.93% |
| 1993 Q3 | 2.9 Million USD | -12.12% |
| 1992 Q4 | 2.7 Million USD | 0.0% |
| 1992 FY | 2.7 Million USD | -6.9% |
| 1991 Q4 | 2.9 Million USD | 0.0% |
| 1991 FY | 2.9 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott Laboratories | 34.38 Billion USD | 86.191% |
| Allurion Technologies Inc. | 142.19 Million USD | -3239.23% |
| Artivion, Inc. | 510.61 Million USD | -829.924% |
| Avanos Medical, Inc. | 456.1 Million USD | -941.077% |
| Butterfly Network, Inc. | 84.22 Million USD | -5537.966% |
| Butterfly Network, Inc. | 84.22 Million USD | -5537.966% |
| Bio-Rad Laboratories, Inc. | 3.55 Billion USD | -33.458% |
| Boston Scientific Corporation | 15.6 Billion USD | 69.574% |
| CONMED Corporation | 1.46 Billion USD | -223.943% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | -79.603% |
| Paragon 28, Inc. | 162.95 Million USD | -2813.85% |
| Glaukos Corporation | 478.64 Million USD | -892.034% |
| Globus Medical, Inc. | 1.08 Billion USD | -336.38% |
| Inspire Medical Systems, Inc. | 104.29 Million USD | -4452.721% |
| Integer Holdings Corporation | 1.41 Billion USD | -235.994% |
| Medtronic plc | 39.56 Billion USD | 87.997% |
| Myomo, Inc. | 5.59 Million USD | -84809.977% |
| Nevro Corp. | 330.31 Million USD | -1337.539% |
| Owlet, Inc. | 73.79 Million USD | -6334.167% |
| Penumbra, Inc. | 377.36 Million USD | -1158.305% |
| Vicarious Surgical Inc. | 21.89 Million USD | -21586.919% |
| Smith & Nephew plc | 4.77 Billion USD | 0.454% |
| Sonendo, Inc. | 49.74 Million USD | -9446.151% |
| Stryker Corporation | 21.31 Billion USD | 77.727% |
| Vapotherm, Inc. | 132.95 Million USD | -3471.505% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | 47.291% |